SAB Biotherapeutics Inc.

NASDAQ: SABSW · Real-Time Price · USD
0.02
-0.02 (-48.98%)
At close: Jun 09, 2025, 11:03 AM

SAB Biotherapeutics Statistics

Share Statistics

SAB Biotherapeutics has 9.29M shares outstanding. The number of shares has increased by -99.14% in one year.

9.29M
-99.14%
0%
9.5%
7.49M
290
1.38%

Short Selling Information

The latest short interest is 13.46K, so 0% of the outstanding shares have been sold short.

13.46K
n/a
n/a
8.9

Valuation Ratios

The PE ratio is -1.03 and the forward PE ratio is null. SAB Biotherapeutics's PEG ratio is 0.02.

-1.03
n/a
26.54
0.6
1.35
-1.01
0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for SAB Biotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.18.

2.98
2.98
0.18
-0.16
-0.13
-134.77

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$20,990.63
$-541,354.11
63
0.03
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 37.46% in the last 52 weeks. The beta is 0.55, so SAB Biotherapeutics's price volatility has been higher than the market average.

0.55
37.46%
0.03
0.05
61.26
20,980

Income Statement

In the last 12 months, SAB Biotherapeutics had revenue of 1.32M and earned -34.11M in profits. Earnings per share was -3.68.

1.32M
-3.47M
-42.91M
-34.11M
-28.99M
-33.79M
-3.68
Full Income Statement

Balance Sheet

The company has 8.9M in cash and 4.67M in debt, giving a net cash position of 4.23M.

8.9M
4.67M
4.23M
-124.17M
38.12M
6.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -34.29M and capital expenditures -337.26K, giving a free cash flow of -34.63M.

-34.29M
-337.26K
-34.63M
-3.74
Full Cash Flow Statement

Margins

Gross margin is -262.41%, with operating and profit margins of -3244.87% and -2579.03%.

-262.41%
-3244.87%
-2579.03%
-2579.03%
-2192.54%
-3244.87%
-2618.65%

Dividends & Yields

SABSW does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for SABSW.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-7.95
2